Etiopathogenesis of inflammatory bowel diseases

被引:74
作者
Danese, Silvio
Fiocchi, Claudio
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA
[2] Ist Clin Humanitas IRCCS Gastroenterol, Div Gastroenterol, Milan, Italy
[3] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA
关键词
inflammatory bowel disease; chronic inflammation; mucosal immunity; innate immunity; adaptive immunity; environment; commensal flora;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Theories explaining the etiopathogenesis of inflammatory bowel disease (IBD) have been proposed ever since Crohn's disease (CD) and ulcerative colitis (UC) were recognized as the two major forms of the disease. Although the exact cause(s) and mechanisms of tissue damage in CD and UC have yet to be completely understood, enough progress has occurred to accept the following hypothesis as valid: IBD is an inappropriate immune response that occurs in genetically susceptible individuals as the result of a complex interaction among environmental factors, microbial factors, and the intestinal immune system. Among an almost endless list of environmental factors, smoking has been identified as a risk factor for CD and a protective factor for UC. Among microbial factors, no convincing evidence indicates that classical infectious agents cause IBD, while mounting evidence points to an abnormal immune response against the normal enteric flora as being of central importance. Gut inflammation is mediated by cells of the innate as well as adaptive immune systems, with the additional contribution of non-immune cells, such as epithelial, mesenchymal and endothelial cells, and platelets. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:4807 / 4812
页数:6
相关论文
共 72 条
[1]
Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases [J].
Bach, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :911-920
[2]
Matrix metalloproteinase levels are elevated in inflammatory bowel disease [J].
Baugh, MD ;
Perry, MJ ;
Hollander, AP ;
Davies, DR ;
Cross, SS ;
Lobo, AJ ;
Taylor, CJ ;
Evans, GS .
GASTROENTEROLOGY, 1999, 117 (04) :814-822
[3]
Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion [J].
Binion, DG ;
Rafiee, P ;
Ramanujam, KS ;
Fu, SD ;
Fisher, PJ ;
Rivera, MT ;
Johnson, CP ;
Otterson, MF ;
Telford, GL ;
Wilson, KT .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (09) :881-888
[4]
Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease [J].
Binion, DG ;
West, GA ;
Ina, K ;
Ziats, NP ;
Emancipator, SN ;
Fiocchi, C .
GASTROENTEROLOGY, 1997, 112 (06) :1895-1907
[5]
Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease [J].
Binion, DG ;
West, GA ;
Volk, EE ;
Drazba, JA ;
Ziats, NP ;
Petras, RE ;
Fiocchi, C .
LANCET, 1998, 352 (9142) :1742-1746
[6]
Hope for the hygiene hypothesis: When the dirt hits the fan [J].
Borchers, AT ;
Keen, CL ;
Gershwin, ME .
JOURNAL OF ASTHMA, 2005, 42 (04) :225-247
[7]
Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? [J].
Campieri, M ;
Gionchetti, P .
GASTROENTEROLOGY, 1999, 116 (05) :1246-1249
[8]
Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease [J].
Cario, E ;
Podolsky, DK .
INFECTION AND IMMUNITY, 2000, 68 (12) :7010-7017
[9]
POSSIBLE ROLE OF MYCOBACTERIA IN INFLAMMATORY BOWEL-DISEASE .1. AN UNCLASSIFIED MYCOBACTERIUM SPECIES ISOLATED FROM PATIENTS WITH CROHNS-DISEASE [J].
CHIODINI, RJ ;
VANKRUININGEN, HJ ;
THAYER, WR ;
MERKAL, RS ;
COUTU, JA .
DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (12) :1073-1079
[10]
Changing patterns of infectious disease [J].
Cohen, ML .
NATURE, 2000, 406 (6797) :762-767